| CAT No: | CL-PCRT-02 |
| CAS No: | NA |
| Mol.F: | C28H30N4O4 |
| Mol.Wt.: | 486.6 |
| Chemical Name: | (E)-1-(2-(6,11-Dioxa-3-aza-2(4,2)-pyrimidina-1,4(1,3)-dibenzenacyclododecaphan-8-en-44-yloxy)ethyl)pyrrolidin-2-one |
| Inventory Status: | Custom synthesis |
This impurity is related to Pacritinib M1 Metabolite is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Asenapine.
Pacritinib M1 Metabolite is used as a reference standard in analytical research. It ensures consistency of formulations.
Chemical Name:(E)-1-(2-(6,11-Dioxa-3-aza-2(4,2)-pyrimidina-1,4(1,3)-dibenzenacyclododecaphan-8-en-44-yloxy)ethyl)pyrrolidin-2-oneCountry of Origin: India Product Category: Impurity Reference StandardAPI NAME: Pacritinib Molecular Formula: C28H30N4O4
Molecular Weight: 486.6
Storage: Store in a cool, dry place.
| Product Name: | Pacritinib M1 Metabolite |
| CAS No: | |
| Mol.F.: | C28H30N4O4 |
| Mol.Wt.: | 486.6 |
Cat. No: CL-PCRT-03
CAS No: NA
Mol. F: C22H21N3O3
Mol. Wt: 375.4
Inv. Status: Custom Synthesis
Cat. No: CL-PCRT-04
CAS No: 1312603-75-0
Mol. F: C24H24ClN3O3
Mol. Wt: 437.9
Inv. Status: Custom Synthesis
Cat. No: CL-PCRT-05
CAS No: 1312603-57-8
Mol. F: C26H28ClN3O3
Mol. Wt: 466
Inv. Status: Custom Synthesis
Cat. No: CL-PCRT-06
CAS No: NA
Mol. F: C28H32N4O4
Mol. Wt: 488.6
Inv. Status: Custom Synthesis
Catalog No:
CAS No:
Mol. Formula:
Mol. Weight:
Chemical Name
Inv Status: